issues with glp 1 drugs GLP-1 medication side effects for diabetes and weight loss Adverse effects of GLP-1 class

President, Lilly Cardiometabolic Health and President, Lilly USA, said Lilly plans to planning to bolster its marketing of Mounjaro and launch efforts to boost demand for Zepbound, including a direct-to-consumer marketing campaign, in earnest in mid-November

Growing Use in Obesity Treatment: As GLP-1 receptor agonists gain recognition as an effective treatment for obesity, the parenteral route remains the preferred method due to its efficiency in delivering the necessary dosage for weight management

Future Perspectives/Conclusions In the search for an anti-obesity pharmacotherapeutic which can rival the weight loss effects of bariatric surgery, research and development of gut hormone co-agonists is gaining momentum

Its refinement, he said.